COVID-19 Drug design and Development

COVID-19 medicate advancement is the inquire about handle to create preventative helpful medicine drugs that would reduce the seriousness of coronavirus illness 2019 (COVID-19). From early 2020 through 2021, a few hundred medicate companies, biotechnology firms, college investigate bunches, and wellbeing organizations were creating restorative candidates for COVID-19 infection in different stages of preclinical or clinical investigate (506 add up to candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as of April 2021.

    Related Conference of COVID-19 Drug design and Development

    November 28-29, 2024

    38th International Conference on Immunology

    Aix-en-Provence, France
    December 12-13, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland
    April 14-15, 2025

    12th World Congress and Exhibition on Antibiotics and Antibiotic Resistance

    Paris, France
    May 05-06, 2025

    6th World Congress on Neuroimmunology and Neuroinfectious Diseases

    Rome, Italy
    May 19-20, 2025

    3rd World Congress on Infectious and Contagious Disease

    Rome, Italy
    May 22-23, 2025

    6th International Conference on Immunology and Radiotherapy

    Toronto, Canada
    June 16-17, 2025

    19th International Conference on European Immunology

    Frankfurt, Germany
    August 26-27, 2025

    6th International conference on Vaccines, Vaccination and Immunization

    Paris, France

    COVID-19 Drug design and Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in